André Juffer

Dr. André Juffer

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2020 in Processes
Verified
Journal Article
Open access
PDF file
Outi Salo-AhenOuti Salo-Ahen
Outi Salo-Ahen
IAIda Alanko
Ida Alanko
Rajendra BhadaneRajendra Bhadane
Rajendra Bhadane
ABAlexandre M.J.J. Bonvin
Alexandre M.J.J. Bonvin
RHRodrigo Vargas Honorato
Rodrigo Vargas Honorato
MVMichiel Vanmeert
Michiel Vanmeert
Molecular dynamics (MD) simulations have become increasingly useful in the modern drug development process. In this review, we give a broad overview of the current application possibilities of MD in drug discovery and pharmaceutical development. Starting from the target validation step of the drug development process, we give several examples of how MD studies can give important insights into the dynamics and function of identified drug targets such as sirtuins, RAS proteins, or intrinsically disordered proteins. The role of MD in antibody design is also reviewed. In the lead discovery and lead optimization phases, MD facilitates the evaluation of the binding energetics and kinetics of the ligand-receptor interactions, therefore guiding the choice of the best candidate molecules for further development. The importance of considering the biological lipid bilayer environment in the MD simulations of membrane proteins is also discussed, using G-protein coupled receptors and ion channels as well as the drug-metabolizing cytochrome P450 enzymes as relevant examples. Lastly, we discuss the emerging role of MD simulations in facilitating the pharmaceutical formulation development of drugs and candidate drugs. Specifically, we look at how MD can be used in studying the crystalline and amorphous solids, the stability of amorphous drug or drug-polymer formulations, and drug solubility. Moreover, since nanoparticle drug formulations are of great interest in the field of drug delivery research, different applications of nano-particle simulations are also briefly summarized using multiple recent studies as examples. In the future, the role of MD simulations in facilitating the drug development process is likely to grow substantially with the increasing computer power and advancements in the development of force fields and enhanced MD methodologies.

1 November 2012 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
PHPeter Henriksen
Peter Henriksen
SWSebastian A. Wagner
Sebastian A. Wagner
BWBrian T. Weinert
Brian T. Weinert
SSSatyan Sharma
Satyan Sharma
GBGiedrė Bačinskaja
Giedrė Bačinskaja
CCChunaram Choudhary
Chunaram Choudhary
Post-translational modification of proteins by lysine acetylation plays important regulatory roles in living cells. The budding yeast Saccharomyces cerevisiae is a widely used unicellular eukaryotic model organism in biomedical research. S. cerevisiae contains several evolutionary conserved lysine acetyltransferases and deacetylases. However, only a few dozen acetylation sites in S. cerevisiae are known, presenting a major obstacle for further understanding the regulatory roles of acetylation in this organism. Here we use high resolution mass spectrometry to identify about 4000 lysine acetylation sites in S. cerevisiae. Acetylated proteins are implicated in the regulation of diverse cytoplasmic and nuclear processes including chromatin organization, mitochondrial metabolism, and protein synthesis. Bioinformatic analysis of yeast acetylation sites shows that acetylated lysines are significantly more conserved compared with nonacetylated lysines. A large fraction of the conserved acetylation sites are present on proteins involved in cellular metabolism, protein synthesis, and protein folding. Furthermore, quantification of the Rpd3-regulated acetylation sites identified several previously known, as well as new putative substrates of this deacetylase. Rpd3 deficiency increased acetylation of the SAGA (Spt-Ada-Gcn5-Acetyltransferase) complex subunit Sgf73 on K33. This acetylation site is located within a critical regulatory domain in Sgf73 that interacts with Ubp8 and is involved in the activation of the Ubp8-containing histone H2B deubiquitylase complex. Our data provides the first global survey of acetylation in budding yeast, and suggests a wide-ranging regulatory scope of this modification. The provided dataset may serve as an important resource for the functional analysis of lysine acetylation in eukaryotes.

1 November 1991 in Journal of Computational Physics
Verified
Journal Article
Closed access
AJAndré Juffer
André Juffer
EBEugen F.F Botta
Eugen F.F Botta
BKBert A.M van Keulen
Bert A.M van Keulen
APAuke van der Ploeg
Auke van der Ploeg
HBHerman J.C Berendsen
Herman J.C Berendsen

1 January 2004 in Journal of Molecular Biology
Verified
Journal Article
Closed access
ALA.K. Lappi
A.K. Lappi
MLMarc Lensink
Marc Lensink
HAH.I. Alanen
H.I. Alanen
KSK.E.H. Salo
K.E.H. Salo
MLM. Lobell
M. Lobell
LRL.W. Ruddock
L.W. Ruddock

29 May 2007 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
RMRaili Myllylä
Raili Myllylä
CWChunguang Wang
Chunguang Wang
JHJari Heikkinen
Jari Heikkinen
AJAndré Juffer
André Juffer
OLOuti Lampela
Outi Lampela
LSLaura Sipilä
Laura Sipilä

1 January 1995 in Journal of Computational Chemistry
Verified
Journal Article
Closed access
PDF file
AVA. H. De Vries
A. H. De Vries
PDP. Th. Van Duijnen
P. Th. Van Duijnen
AJAndré Juffer
André Juffer
JRJ. A. C. Rullmann
J. A. C. Rullmann
JDJ. P. Dijkman
J. P. Dijkman
BTB. T. Thole
B. T. Thole